Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT00097877 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

293

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S